MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201631/12/201531/12/2014
Total revenue39,807,00039,498,00042,237,000
Cost of revenue13,891,00014,934,00016,768,000
Gross profit25,916,00024,564,00025,469,000
Operating expenses
Research development10,124,0006,704,0007,180,000
Selling general and administrative9,762,00010,313,00011,606,000
Non-recurring651,000619,0001,013,000
Others---
Total operating expenses---
Operating income or loss5,379,0006,928,0005,670,000
Income from continuing operations
Total other income/expenses net-720,000-1,527,00011,613,000
Earnings before interest and taxes4,659,0005,401,00017,283,000
Interest expense---
Income before tax4,659,0005,401,00017,283,000
Income tax expense718,000942,0005,349,000
Minority interest220,00091,000144,000
Net income from continuing ops3,920,0004,442,00011,920,000
Non-recurring events
Discontinued operations---
Extraordinary items---
Effect of accounting changes---
Other items---
Net income
Net income3,920,0004,442,00011,920,000
Preferred stock and other adjustments---
Net income applicable to common shares3,920,0004,442,00011,920,000